Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (297)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
FRANÇAIS : Ce rapport de l'OEDT offre un tour d'horizon du phénomène de la toxicomanie en Europe : il fournit des renseignements sur les différents types de consommation, des données comparatives d'ordre épidémiologique ou encore des chiffres [...]Rapport
Cette première édition révèle que le problème de drogue dans ces pays diffère radicalement de la situation d'il y a cinq à sept ans. Traditionnellement considérés comme des pays de "transit", ils sont devenus aujourd'hui une cible pour ce qui co[...]Rapport
This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the b[...]Rapport
This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the b[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institu[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7[...]Rapport
Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that ar[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : Dans nombre de pays européens, les amphétamines (terme générique regroupant l'amphétamine et la méthamphétamine) ou l'ecstasy sont la deuxième drogue illicite la plus répandue. En outre, dans certains pays, la consommation d'amphétam[...]Rapport
This report presents new findings from the ESCAPE (European Syringe Collection and Analysis Project Enterprise) network, based on the chemical analysis of the contents of used syringes across sentinel sites in Europe. Syringes were collected in [...]Rapport
OEDT = EMCDDA ; A. HEINEMANN ; S. IWERSEN-BERGMANN | Lisbon : OEDT / EMCDDA | Technical reports | 2019The objective of this report is to provide an updated analysis of the post-mortem toxicology practices of drug-related deaths (DRD) in Europe and to discuss the effect of these practices on the monitoring of DRDs. It is based on the results of a[...]Rapport
OEDT = EMCDDA ; M. CLAESSENS ; W. HARDYNS ; F. VANDER LAENEN ; N. VERHAEGHE | Lisbon : OEDT / EMCDDA | 2019The production of synthetic drugs, measured by the number of manufacturing sites identified and the amount of drugs seized, shows an increasing trend. In the Netherlands, Schoenmakers and Mehlbaum (2017) recorded a rise in the number of sites us[...]Rapport
Online anonymous marketplaces are a relatively recent technological development that enables sellers and buyers to transact online with far stronger anonymity guarantees than are available on traditional electronic commerce platforms. This has l[...]Rapport
OEDT = EMCDDA ; S. CASTIGLIONI, Éditeur scientifique ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016"Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology" reviews a new approach to estimating drug use in populations, based on the detection and quantification of drugs and their metabolic products in community wa[...]Rapport
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverte[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : Le cannabis est la drogue illicite la plus largement répandue en Europe, où elle est tout à la fois importée et produite. Dans la plupart des pays d'Europe, la consommation de cannabis a augmenté durant les années 1990 et au début de[...]Rapport
This publication answers some of the more frequently asked questions raised in discussions about cannabis legislation. While the primary focus is on the use of cannabis for recreational purposes, relevant legislation for other uses, including me[...]Rapport
At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the[...]Rapport
OEDT = EMCDDA ; C. CARPENTIER ; K. MULLIGAN ; L. LANIEL ; D. J. POTTER ; B. HUGHES ; L. VANDAM ; D. OLSZEWSKI ; K. SKARUPOVA | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2012FRANÇAIS : « La part de marché de l'herbe de cannabis augmente en Europe, aux dépens de celle de la résine de cannabis ». Telle est l'information qui ressort de la première analyse détaillée de la Production et des marchés du cannabis en Europe[...]